Stay updated on Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to a Phase III randomized trial evaluating the addition of nivolumab to cisplatin-RT for the treatment of cancers of the head and neck.
    Difference
    0.1%
    Check dated 2024-06-06T14:21:33.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed eligibility criteria for study participants, including age, health status, and specific medical history requirements. This change offers more comprehensive information for researchers to identify suitable candidates for the clinical trial.
    Difference
    44%
    Check dated 2024-05-22T20:20:51.000Z thumbnail image
  8. Check
    43 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2024-04-30T22:28:11.000Z thumbnail image

Stay in the know with updates to Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page.